Botulinum Toxin Type E Terminated Phase 2 Trials for Abdominoplasty Surgery Treatment

Back to Botulinum Toxin Type E
IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03429556
Study to Evaluate Botulinum Neurotoxin Serotype E (EB-001) in Reducing Musculoskeletal Pain in Abdominoplasty